Evidence map›Paper›PMID 42015552›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Beyond Bloodstream Infection: The Potential for Hierarchical Composite Endpoints in Vascular Access Research.

Carl Mellander, Andrew J Martin, Gaurav Langan, Stefanie Seifert, Fredrik Hammarskjöld, Knut Taxbro, Claire M Rickard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carl MellanderDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0009-0006-9374-8326
Andrew J MartinClinical Trial Capability (ULTRA), The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-5804-2295
Gaurav LanganSchool of Nursing, Midwifery and Social Work, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0009-0007-3287-7826
Stefanie SeifertDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-5986-4004
Fredrik HammarskjöldDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0002-4358-7820
Knut TaxbroDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-8711-9044
Claire M RickardFaculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-6341-7415

Funding

University of Queensland
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42015552
PMCPMC13644862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.